RooLife Group Secures $2 Million in Oversubscribed Capital Raise to Accelerate Global Expansion

Highlights:

• RooLife Group Ltd (ASX: RLG) raises $2 million through an oversubscribed placement at $0.007 per share, with strong institutional investor demand.
• Funds to drive expansion in China, India, Southeast Asia, and the UK, strengthen working capital, and fulfil supply deal with Eternal Asia.
• Investors to receive 142.86 million RLGO options, exercisable at $0.01 and expiring in September 2026, subject to shareholder approval.

11 August 2025 — RooLife Group Ltd (ASX: RLG) has announced the successful completion of an oversubscribed strategic placement, raising $2 million from institutional and sophisticated investors. Shares were issued at $0.007 each, representing a 12.5% discount to the last traded price of $0.008 and a 75% premium to the prior day’s closing price of $0.004. At the time of writing, RooLife Group shares were trading at $0.008.

Strong Investor Demand Drives Oversubscription

The placement, led by Alpine Capital Pty Ltd, involved issuing 285.7 million new shares under the company’s placement capacity in accordance with ASX Listing Rules 7.1 and 7.1A. The high level of institutional interest resulted in the offering being significantly oversubscribed, underscoring market confidence in RooLife Group’s growth prospects.

Alongside the share issuance, investors will receive 142.86 million RLGO options, exercisable at $0.01 and expiring on 26 September 2026, subject to shareholder approval.

Funding Strategy and Growth Focus

Proceeds from the capital raise will be deployed to:

• Expand sales in key international markets including China, India, Southeast Asia, and the UK.
   
• Strengthen working capital to support scaling initiatives.
   
• Advance the RLG Marketplace e-commerce platform globally.
   
• Drive sales of the company’s own branded product range.
   
• Fulfil the two-year supply agreement with major Chinese distribution partner Eternal Asia.

Positioning for Long-Term Performance

Management stated that the strategic deployment of funds will position RooLife Group for enhanced operational scale and stronger financial performance. The allocation reflects the company’s focus on leveraging e-commerce growth trends while maintaining a balanced approach to expansion. Allotment of the new shares is scheduled for 20 August 2025, with the placement marking a key step in the company’s global growth journey.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com